EUVIMEDEUVIMED entdecken
Crossref

Improvement of the loss of corneal endothelial cells by relocating the tip of the Baerveldt® implant tube from the anterior chamber to the vitreous cavity

Yuuki Honda, Akio Miyakoshi, Naoki Tojo, Atsushi Hayashi

International Ophthalmology · 2023

DOI: 10.1007/s10792-023-02677-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Ophthalmology, 2023. Verfasst von Yuuki Honda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. Hauptthemen laut MEDLINE: Glaucoma, Glaucoma Drainage Implants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: It has been reported that corneal endothelial cells (CEC) decrease faster when the tip of the Baerveldt glaucoma implant (BGI) tube is inserted into the anterior chamber than into the vitreous cavity. We investigated whether surgically relocating the tip of the BGI tube from the anterior chamber to the vitreous cavity could reduce CEC loss. PATIENTS AND METHODS: This was a single facility retrospective cohort study. The inclusion criteria were the CEC density less than 1500 cells/mm2 and the CEC reduction ratio was greater than 10%/year. The subjects were 11 consecutive patients that could be followed > 12 months after relocation surgery. All patients were undergone vitrectomy, and the tip of tube was inserted into the vitreous cavity from the anterior chamber. We compared the intraocular pressure (IOP), reduction slope of CEC density and annual reduction rate of CEC density before and after relocation surgery. We calculated the annual reduction ratio in comparison with the preoperative CEC density (%/year). RESULTS: The mean of period between the Baeveldt with anterior chamber insertion surgery and the relocation surgery was 33.8 ± 15.0 months. The mean of follow-up after relocation surgery was 21.8 ± 9.8 months. The relocation surgery did not significantly change IOP (p = 0.974). The mean preoperative and postoperative IOP were 13.1 ± 4.5 and 13.6 ± 4.3 mmHg. The reduction ratio of the CEC density was 15.4 ± 6.7 (%/year) before relocation surgery and significantly slower at 8.3 ± 6.5 (%/year) after relocation surgery (p = 0.024). Two patients resulted in bullous keratopathy after relocation surgery. CONCLUSIONS: Relocating the tip of BGI tube from the anterior chamber to the vitreous cavity could reduce CEC loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlaucomaGlaucoma Drainage ImplantsHumansRetrospective StudiesEndothelial CellsTreatment OutcomeProsthesis ImplantationIntraocular PressureAnterior ChamberFollow-Up Studies

Stichwörter der Autor:innen

Anterior chamberBaerveldt glaucoma implantCorneal endothelial lossRelocationVitreous cavity

Autor:innen und Institutionen

  • Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
  • Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. tojo2005nm@yahoo.co.jp.

Zitieren

APA

Honda, Y., Miyakoshi, A., Tojo, N., & Hayashi, A. (2023). Improvement of the loss of corneal endothelial cells by relocating the tip of the Baerveldt® implant tube from the anterior chamber to the vitreous cavity. International Ophthalmology. https://doi.org/10.1007/s10792-023-02677-3

Vancouver

Honda Y, Miyakoshi A, Tojo N, Hayashi A. Improvement of the loss of corneal endothelial cells by relocating the tip of the Baerveldt® implant tube from the anterior chamber to the vitreous cavity. International Ophthalmology. 2023. doi:10.1007/s10792-023-02677-3

BibTeX
@article{Honda2023,
  author = {Honda, Yuuki and Miyakoshi, Akio and Tojo, Naoki and Hayashi, Atsushi},
  title = {Improvement of the loss of corneal endothelial cells by relocating the tip of the Baerveldt® implant tube from the anterior chamber to the vitreous cavity},
  journal = {International Ophthalmology},
  year = {2023},
  doi = {10.1007/s10792-023-02677-3}
}
Kostenlos starten →